Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
Systemic and renal lipids in kidney disease development and progression
Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.
Lipid biology of the podocyte--new perspectives offer new opportunities.
Renal lipid metabolism and lipotoxicity.
Cyclodextrin Protects Podocytes in Focal Segmental Glomerulosclerosis (FSGS)
Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
Cyclodextrin improves renal function in experimental alport syndrome.
Cyclodextrin protects podocytes in diabetic kidney disease.